Notice · For research and educational reference. Not medical advice. Intended for licensed professionals. Nothing on this site is offered for sale other than informational access.

All Info Peptides
All monographs

Multi-Peptide Blends

Tesa/Ipa 2X Blend (12mg / 3mg)

Also known as · Tesamorelin + Ipamorelin 12/3

Overview

A 4:1 (12 mg / 3 mg) GHRH-weighted blend studied for amplified GHRH signaling with a lower-dose secretagogue co-stimulus.

Research profile · for clinicians

Based on research: a GHRH-weighted version of the tesamorelin + ipamorelin combination for studies emphasizing baseline GHRH-receptor tone with a smaller secretagogue co-stimulus.

Mechanism of action

Higher tesamorelin content drives GHRH-receptor activation; the lower ipamorelin component provides adjunct GHSR-1a tone for synchronized pulse amplification.

Research record

  • [01]Derived from the same mechanistic body of work as the 5/5 ratio.
  • [02]No published clinical trials of the fixed-ratio blend.

Selected references

  • Tesamorelin pharmacology review

    Drugs, 2011